Literature DB >> 28300286

Clinical Significance and Prognosis Value of Wnt Signaling Pathway in Cervical Cancer.

Afsane Bahrami1, Malihe Hasanzadeh2, Soodabeh ShahidSales3, Zohre Yousefi2, Sima Kadkhodayan2, Marjaneh Farazestanian2, Mona Joudi Mashhad3, Masoumeh Gharib4, Seyed Mahdi Hassanian5,6, Amir Avan6.   

Abstract

Cervical cancer is among the most commonly diagnosed cancer in women, supporting the need for identification of novel prognostic and predictive biomarkers to predict the risk of developing of this malignancy or predict the prognosis of patients. Against this background, the activation of the Wingless-type (Wnt)/β-catenin pathway has been suggested as the main dysregulated pathways, which is involved in the multistep process of cervical carcinogenesis, suggesting its value as a potential biomarker or therapeutic target. The aim of current review is to give an overview about the potential application of WNT pathway and its value which is differentially expressed in cervical cancer versus non-tumorigenic tissue as biomarker for risk stratification and predict the prognosis of patients with cervical cancer. J. Cell. Biochem. 118: 3028-3033, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  CERVICAL CANCER; PATIENTS; WNT PATHWAY

Mesh:

Substances:

Year:  2017        PMID: 28300286     DOI: 10.1002/jcb.25992

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  34 in total

1.  MicroRNA-758 inhibits cervical cancer cell proliferation and metastasis by targeting HMGB3 through the WNT/β-catenin signaling pathway.

Authors:  Tao Song; Xinghua Hou; Bing Lin
Journal:  Oncol Lett       Date:  2019-06-12       Impact factor: 2.967

2.  Activation of the Wnt/β-catenin signaling pathway may contribute to cervical cancer pathogenesis via upregulation of Twist.

Authors:  Xiaohong Sun; Yu Liu
Journal:  Oncol Lett       Date:  2017-08-14       Impact factor: 2.967

3.  Proteomics analysis of proteins interacting with heat shock factor 1 in squamous cell carcinoma of the cervix.

Authors:  Lingli Zhang; Zhe Hu; Ying Zhang; Jinzhi Huang; Xuefen Yang; Jiafeng Wang
Journal:  Oncol Lett       Date:  2019-06-27       Impact factor: 2.967

4.  Gefitinib suppresses cervical cancer progression by inhibiting cell cycle progression and epithelial-mesenchymal transition.

Authors:  Jianyun Zheng; Jianxin Yu; Min Yang; Li Tang
Journal:  Exp Ther Med       Date:  2019-07-09       Impact factor: 2.447

5.  Identifying a cervical cancer survival signature based on mRNA expression and genome-wide copy number variations.

Authors:  Nan Li; Kai Yu; Zhong Lin; Dingyuan Zeng
Journal:  Exp Biol Med (Maywood)       Date:  2021-10-21

6.  [ENTPD5 gene is highly expressed in epithelial ovarian cancer: analysis based on Oncomine database and bioinformatics].

Authors:  H Wang; X Chen; Y Chen; Y Cao; Y Chen; G Liu; L Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-04-20

7.  A mechanism of regucalcin knock-down in the promotion of proliferation and movement of human cervical cancer HeLa cells.

Authors:  Xiaolong Li; Yingwen Huang; Pengfei Wang; Wei Song; Qingmei Yao; Qiping Hu; Sufang Zhou
Journal:  Transl Cancer Res       Date:  2019-04       Impact factor: 1.241

8.  Exosome-Mediated Transfer of miR-1323 from Cancer-Associated Fibroblasts Confers Radioresistance of C33A Cells by Targeting PABPN1 and Activating Wnt/β-Catenin Signaling Pathway in Cervical Cancer.

Authors:  Fang Fang; Chunfeng Guo; Weinan Zheng; Qin Wang; Limei Zhou
Journal:  Reprod Sci       Date:  2022-03-25       Impact factor: 3.060

Review 9.  Wnt signaling in cervical cancer?

Authors:  Min Yang; Min Wang; Xianping Li; Yixin Xie; Xiaomeng Xia; Jingjing Tian; Kan Zhang; Aiguo Tang
Journal:  J Cancer       Date:  2018-03-20       Impact factor: 4.207

10.  Metabolism-Relevant Molecular Classification Identifies Tumor Immune Microenvironment Characterization and Immunotherapeutic Effect in Cervical Cancer.

Authors:  Luyi Li; Hui Gao; Danhan Wang; Hao Jiang; Hongzhu Wang; Jiajian Yu; Xin Jiang; Changjiang Huang
Journal:  Front Mol Biosci       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.